Waste Products (Waste Product)

Subscribe to Selected New Research on Waste Products

107 relevant articles (3 outcomes, 5 trials/studies) found for this Bio-Agent

Description: Debris resulting from a process that is of no further use to the system producing it. The concept includes materials discharged from or stored in a system in inert form as a by-product of vital activities. (From Webster's New Collegiate Dictionary, 1981)

Also Known As:

Waste Product; Products, Waste; Product, Waste

Relationship Network

Bio-Agent Context: Research Results

Complex Mixtures: 314

Environment and Public Health

Public Health

Environmental Pollution

Experts

1.	Cope, Andrew P: 1 article (09/2006)

Related Diseases

1.	Multiple Organ Failure (MODS) 07/01/1993 - "Continuous venovenous hemodiafiltration, with the Equaline System, is effective for the clearance of waste products and is able to maintain perfect fluid balance in catabolic patients with acute renal failure and multiple organ failure." 08/01/2000 - "Patients with MODS, however, are frequently catabolic and have a high urea generation rate requiring either cost-intensive high-volume CRRT or additional intermittent haemodialysis to provide adequate clearance of small-molecular waste products. " Order ALL the reference details at left...
2.	Acute Kidney Failure (Acute Renal Failure) 05/01/2007 - "Acute renal failure is a sudden and sustained decrease in the glomerular filtration rate associated with a loss of excretory function and the accumulation of metabolic waste products and water. " 04/01/2002 - "Acute renal failure (ARF) is defined as a rapid, sudden onset deterioration of renal function (glomerular filtration rate, GFR) with the ensuing accumulation of uraemic waste products. " 07/01/1993 - "Continuous venovenous hemodiafiltration, with the Equaline System, is effective for the clearance of waste products and is able to maintain perfect fluid balance in catabolic patients with acute renal failure and multiple organ failure." 06/01/1988 - "Models of ischemic acute renal failure (ARF) must consider the combination of tissue hypoxia, insufficient nutrient flow, and anaerobic waste product accumulation. " 02/01/2009 - "Acute kidney injury (AKI) (previously called acute renal failure) is characterized by a reversible increase in the blood concentration of creatinine and nitrogenous waste products and by the inability of the kidney to regulate fluid and electrolyte homeostasis appropriately. " Order ALL the reference details at left...
3.	Second Primary Neoplasms (Neoplasms, Second) 01/01/2007 - "Second, cancer cell mitochondria often exhibit a reduced oxidative phosphorylation, meaning that ATP is generated through the conversion of glucose to pyruvate and excess pyruvate is then eliminated as the waste product lactate. " Order ALL the reference details at left...
4.	Neoplasms (Cancer) 02/01/2008 - "Critically, new cancer risk factors have also appeared, concurrent with globalization: modern diet, addictive products, pharmaceuticals, and toxic and waste products. " 05/15/1991 - "Ischemic stress of cells within solid tumors arises from inadequate perfusion of regions of the tumor and results in microenvironments which are hypoxic and deficient in nutrient delivery and waste product removal. " 01/01/1982 - "It is highly unlikely that viable tumor cells do occur in the waste products of CO2-laser tumor vaporization." 04/01/2004 - "The blood-vessel network provides not only nutritional support and waste product management, but also offers opportunities for the secondary spread of tumor cells. " 02/01/2006 - "The data presented in this study, indicates that this waste product along with CNSL, both of which contain high contents of anacardic acids, could be better utilized in functional food formulations and may represent a cheap source of cancer chemopreventive agents." Order ALL the reference details at left...
5.	Gastroschisis 03/01/2004 - "Several studies in animal models demonstrate that peel formation in gastroschisis is due to the accumulation and activation of intestinal waste products (IWP) in the amniotic fluid. " 01/01/2008 - "AF exchange and infusion may prevent intestinal damage and improve postnatal outcome in gastroschisis by diluting the AF, probably by lowering the concentrations of intestinal waste products." 01/01/2008 - "The deleterious effects of AF on gastroschisis can be prevented by lowering the concentration of intestinal waste products. " 01/01/2008 - "In gastroschisis, prolonged exposure of the intestine to amniotic fluid (AF) containing intestinal waste products results in intestinal damage, including intestinal wall thickening and fibrous peel formation. " 01/01/2008 - "Changes in intestinal waste products during the antenatal management of gastroschisis by serial amniotic fluid exchange and infusion." Order ALL the reference details at left...

Related Drugs and Biologics

1.	Urea (Carbamide)
2.	Lactic Acid
3.	Glucose (Dextrose)
4.	Pyruvic Acid (Pyruvate)
5.	Adenosine Triphosphate (ATP)
6.	Anacardic Acids
7.	Heme Oxygenase (Decyclizing) (Heme Oxygenase)
8.	Glutamine (L-Glutamine)
9.	Bilirubin
10.	Arginine (L-Arginine)

Related Therapies and Procedures

1.	Peritoneal Dialysis
2.	Nutritional Support (Artificial Feeding)
3.	Plasma Exchange
4.	Injections
5.	Decompression

Best Treatments:
Research Summary Report
on Multiple Organ Failure

CureHunter Patient-Physician Summary Reports collect in one document all the medications ever reported in the US National Library of Medicine—1949 to the present—to be effective against your target disease. CureHunter research summary reports will vary in length from 25 to 250 pages. Analytic charts allow you and your physicians to see at a glance your medication options—including new, promising, off-label and experimental all rated for clinical efficacy.

Free Updates for 1 Year
All 72 Outcomes
Top 200 Key Drugs and Biologics
Top 50 Key Therapies and Procedures
Detailed History Charts
Full Research Reference Details
Sample PDF Report on Psoriasis >>

Price:

$24.00 & Delivery via PDF download
updates for 1 year

Research Interface

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.

Unlimited Disease, Drug and Therapy Search
2 clicks from Disease to Drug to Evidence
Trial References
All the Positive Outcomes
Detailed Relationship Timeline Charts
Full Article Reference Details
Includes Mobile Interface Subscription
One-click to FDA Products/Patents
Request Institution License Details >>

Price:

$490.00 access via web interface
1 year subscription

Proceed to Checkout >>

Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.

Access from any web enabled PDA or Phone
Trial references
All the Positive Outcomes
Drug and Therapy searches
Full Article Reference Details
Try Mobile Interface >>

Price:

$45.00 access via "curehunter.com/m"
1 year subscription

Proceed to Checkout >>